FDA Approved: ONGENTYS — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for ONGENTYS (opicapone) submitted by Amneal Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ONGENTYS (opicapone)

Snippet

SUPPL AP for ONGENTYS (OPICAPONE)